Over the last several years, the authors have studied the relationship
of insulin-like growth factors (IGFs) and the insulin-like growth fac
tor binding proteins (IGFBPs) in the circulation in a number of clinic
al settings. Patterns have emerged that seem to be characteristic of v
arious conditions. In aging, there are marked decreases in IGF-I and -
II, normal levels of IGFBP-3, and marked increases in IGFBP-1 in serum
. Using ligand blotting and an IGFBP-3 proteolysis assay, BP-3 is inta
ct. Based on native gel electrophoresis, IGFBP-1 is in its most highly
phosphorylated state in those elders who have high IGFBP-1 levels. Th
is pattern is slightly different in catabolic conditions such as AIDS
(wasting in adults; failure to thrive in children), uncontrolled diabe
tes mellitus, trauma, and severe burns. In these conditions, serum lev
els of IGF-I and -II are markedly diminished, IGFBP-3 levels are also
decreased, and IGFBP-1 levels are markedly increased. In addition, the
re is increased proteolysis of IGFBP-3 (AIDS failure to thrive, uncont
rolled diabetes mellitus) and disruption of the ternary complex with d
ecreased levels of ALS (AIDS wasting and burns). IGFBP-1 is in its mos
t highly phosphorylated state in all catabolic conditions studied. Thu
s, the alterations in the circulating levels of IGFs and the changes i
n the physical state of the IGFBPs may lead to decreased anabolic acti
vity and be a part of the mechanism of increased catabolism and wastin
g.